Showing results (301-310 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|May 21, 2013
Mechanism of differentiation-enhanced photodynamic therapy for cancer: upregulation of coproporphyrinogen oxidase by C/EBP transcription factorsSanjay Anand, Tayyaba Hasan, Edward V Maytin
Molecular Cancer Therapeutics|May 22, 2013
Combined targeting of mTOR and AKT is an effective strategy for basal-like breast cancer in patient-derived xenograft modelsSiguang Xu, Shunqiang Li, Zhanfang Guo, et al.
Molecular Cancer Therapeutics|May 23, 2013
PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancerKatherine T Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, et al.
Molecular Cancer Therapeutics|December 4, 2012
It's about time: lessons for solid tumors from chronic myelogenous leukemia therapyJason R Westin, Razelle Kurzrock
Molecular Cancer Therapeutics|December 11, 2012
COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cellsRobert Ramer, Katharina Heinemann, Jutta Merkord, et al.
Molecular Cancer Therapeutics|February 1, 2013
Poly(β-amino ester) nanoparticle delivery of TP53 has activity against small cell lung cancer in vitro and in vivoChandrashekhar D Kamat, Ron B Shmueli, Nick Connis, et al.
Molecular Cancer Therapeutics|January 5, 2013
Targeted degradation of KRAS by an engineered ubiquitin ligase suppresses pancreatic cancer cell growth in vitro and in vivoYihui Ma, Yumei Gu, Qiang Zhang, et al.
Molecular Cancer Therapeutics|January 5, 2013
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft modelSuman Kambhampati, Roger A Rajewski, Mehmet Tanol, et al.
Molecular Cancer Therapeutics|December 18, 2012
Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathwayMei Huang, Hailong Zhang, Tao Liu, et al.
Molecular Cancer Therapeutics|January 17, 2013
Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent mannerAnna R McCarthy, Marijke C C Sachweh, Maureen Higgins, et al.
Pageof 599